Discover the new Chem-Impex: Where innovation starts with a bond.

Catalog Number:
31032
CAS Number:
162635-04-3
Temsirolimus
Purity:
≥ 98 % (HPLC)
Synonym(s):
42-[3-Hidroxi-2-(hidroximetil)-2-metilpropanoato]-rapamicina
Documents
$134.70 /25 mg
Tamaño
Request Bulk Quote
Product Information

Mantener alejado de fuentes de ignición, sustancias incompatibles.

Synonyms
42-[3-Hidroxi-2-(hidroximetil)-2-metilpropanoato]-rapamicina
CAS Number
162635-04-3
Purity
≥ 98 % (HPLC)
Molecular Formula
C 56 H 87 N.º 16
Molecular Weight
1030.29
MDL Number
MFCD00934421
PubChem ID
148191
Melting Point
155 - 162 °C
Appearance
Polvo blanco
Conditions
Conservar a -10 °C
General Information
Synonyms
42-[3-Hidroxi-2-(hidroximetil)-2-metilpropanoato]-rapamicina
CAS Number
162635-04-3
Purity
≥ 98 % (HPLC)
Molecular Formula
C 56 H 87 N.º 16
Molecular Weight
1030.29
MDL Number
MFCD00934421
PubChem ID
148191
Melting Point
155 - 162 °C
Appearance
Polvo blanco
Conditions
Conservar a -10 °C
Properties
Additional property information coming soon!
-
Safety and Regulations
Hazmat
No
Antibiotic
No
DEA-regulated
No
Warnings
-
Applications

Temsirolimus is widely utilized in research focused on

  • Cancer Treatment: Primarily used in oncology, it serves as an effective treatment for advanced renal cell carcinoma, helping to inhibit tumor growth and improve patient outcomes.
  • Research on mTOR Pathway: As an mTOR inhibitor, it is crucial for studies investigating cellular growth and metabolism, providing insights into various diseases, including cancer and metabolic disorders.
  • Combination Therapies: It is often combined with other therapeutic agents to enhance efficacy in cancer treatments, allowing for more personalized and effective treatment regimens.
  • Drug Development: Used in pharmaceutical research to develop new drugs targeting similar pathways, facilitating advancements in cancer therapies and other related conditions.
  • Biomarker Studies: Helps in identifying biomarkers for patient stratification in clinical trials, improving the precision of treatment approaches and outcomes.

Citas